Atossa Therapeutics ATOS
NASDAQ ATOS
$2.27 +0.32 (+16.41%)
At close: Oct 1, 2026 · 4:00 PM EDT

Atossa Therapeutics (ATOS) Receivables - Net (2011 - 2017)

Updated

Atossa Therapeutics' Receivables - Net came in at $4,040 for Q3 2017.

Analysis

Atossa Therapeutics (ATOS) Receivables - Net (2011 - 2017) Analysis & Trends

At the end of FY2014, Atossa Therapeutics' Receivables - Net was $297,958, up 114.2% from FY2013.

  • Receivables - Net carries a three-year compound annual growth rate of 524.4% (FY2011 to FY2014).
  • Going back by year, Receivables - Net was $139,072 in FY2013 (-1.8%), $141,666 in FY2012 and $1,224 in FY2011.
  • The Q3 2017 figure represents the highest quarterly Receivables - Net since Q3 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Atossa Therapeutics 19.46 Mn 19.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 4,040.00
Sep 30, 2015 1.06 Mn
Jun 30, 2015 2.01 Mn
Mar 31, 2015 1.28 Mn
Dec 31, 2014 297,958.00
Sep 30, 2014 29,151.00
Jun 30, 2014 48,155.00
Mar 31, 2014 91,416.00
Dec 31, 2013 139,072.00
Sep 30, 2013 299,338.00
Jun 30, 2013 520,424.00
Mar 31, 2013 259,339.00
Dec 31, 2012 141,666.00
Sep 30, 2012 175,408.00
Dec 31, 2011 1,224.00
API Access

Atossa Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=ATOS&period=max&api_key=YOUR_API_KEY